Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marriott

Showing results (141-150 of 142) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 142 results.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2011
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled studyH Graf, S Fast, F Pacini, et al.
Nature Communications|January 5, 2021
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunityKathryn A Ryan, Kevin R Bewley, Susan A Fotheringham, et al.
Pageof 15

Showing results (141-150 of 142) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 142 results.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2011
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled studyH Graf, S Fast, F Pacini, et al.
Nature Communications|January 5, 2021
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunityKathryn A Ryan, Kevin R Bewley, Susan A Fotheringham, et al.
Pageof 15